Skip to main content

Functional roles of non-coding RNAs in cardiovascular diabetology

Guest Editor:

Gaetano Santulli, MD, PhD, FAHA, Albert Einstein College of Medicine, United States of America

This collection is no longer accepting submissions.


Cardiovascular Diabetology is calling for submissions to our Collection on Functional roles of non-coding RNAs in cardiovascular diabetology. Non-coding RNAs have recently emerged as fundamental players in a number of physiologic and pathologic processes. We are interested in considering manuscripts exploring key aspects of non-coding RNA in basic science as well as in clinical practice, for instance examining their applications as reliable biomarkers of disease and their employment as therapeutic tools.

Image credit: Prof. Gaetano Santulli, MD, PhD

  1. Diabetes mellitus (DM) is a metabolic disease that heightens the risks of many vascular complications, including peripheral arterial disease (PAD). Various types of cells, including but not limited to endothel...

    Authors: Alonso Tapia, Xuejing Liu, Naseeb Kaur Malhi, Dongqiang Yuan, Muxi Chen, Kevin W. Southerland, Yingjun Luo and Zhen Bouman Chen
    Citation: Cardiovascular Diabetology 2024 23:274
    Content type: Review Published on:

  2. Ischemia with non-obstructive coronary artery (INOCA) is a common cause of hospital admissions, leading to negative outcomes and reduced quality of life. Central to its pathophysiology is endothelial dysfuncti...

    Authors: Marco Ferrone, Michele Ciccarelli, Fahimeh Varzideh, Urna Kansakar, Germano Guerra, Federica Andrea Cerasuolo, Antonietta Buonaiuto, Antonella Fiordelisi, Enzo Venga, Mafalda Esposito, Antonio Rainone, Roberto Ricciardi, Carmine Del Giudice, Fabio Minicucci, Tullio Tesorio, Valeria Visco…
    Citation: Cardiovascular Diabetology 2024 23:268
    Content type: Research Published on:

  3. Previous studies have shown that peptides encoded by noncoding RNAs (ncRNAs) can be used as peptide drugs to alleviate diseases. We found that microRNA-31 (miR-31) is involved in the regulation of hypertension...

    Authors: Xiangxiao Li, Hong Zhou, Pengfei Lu, Zilong Fang, Guangzheng Shi, Xinran Tong, Wendong Chen, Gonghao Jiang, Peili Zhang, Jingyan Tian and Qun Li
    Citation: Cardiovascular Diabetology 2024 23:249
    Content type: Research Published on:

  4. In recent years, the incidence of diabetes has been increasing rapidly, posing a serious threat to human health. Diabetic cardiomyopathy (DCM) is characterized by cardiomyocyte hypertrophy, myocardial fibrosis...

    Authors: Xi Yao, Xinyue Huang, Jianghua Chen, Weiqiang Lin and Jingyan Tian
    Citation: Cardiovascular Diabetology 2024 23:227
    Content type: Review Published on:

  5. The specific pathophysiological pathways through which diabetes exacerbates myocardial ischemia/reperfusion (I/R) injury remain unclear; however, dysregulation of immune and inflammatory cells, potentially dri...

    Authors: De-Zhao Liu, Xiao-Zhi Luo, Chuang-Hong Lu, Yang-Yi Feng, De-Xin Chen, Zhi-Yu Zeng and Feng Huang
    Citation: Cardiovascular Diabetology 2024 23:202
    Content type: Research Published on:

  6. Monocytes play a central role in the pathophysiology of cardiovascular complications in type 2 diabetes (T2D) patients through different mechanisms. We investigated diabetes-induced changes in lncRNA genes fro...

    Authors: Najeeb Halabi, Binitha Thomas, Omar Chidiac, Amal Robay, Julien AbiNahed, Amin Jayyousi, Jassim Al Suwaidi, Martina Bradic and Charbel Abi Khalil
    Citation: Cardiovascular Diabetology 2024 23:196
    Content type: Research Published on:

  7. Vascular calcification (VC) is an independent risk factor for cardiovascular diseases. Recently, ferroptosis has been recognised as a novel therapeutic target for cardiovascular diseases. Although an associati...

    Authors: Yierpani Aierken, Huqiang He, Runwen Li, Zipeng Lin, Tongjie Xu, Li Zhang, Ya Wu and Yong Liu
    Citation: Cardiovascular Diabetology 2024 23:186
    Content type: Research Published on:

  8. The long-term high-fat diet (HFD) can cause myocardial lipotoxicity, which is characterized pathologically by myocardial hypertrophy, fibrosis, and remodeling and clinically by cardiac dysfunction and heart fa...

    Authors: Xinzhu Ni, Lian Duan, Yandong Bao, Jinyang Li, Xiaowen Zhang, Dalin Jia and Nan Wu
    Citation: Cardiovascular Diabetology 2024 23:129
    Content type: Research Published on:

  9. The accumulation of visceral and ectopic fat comprise a major cause of cardiometabolic diseases. However, novel drug targets for reducing unnecessary visceral and ectopic fat are still limited. Our study aims ...

    Authors: Min Cao and Bin Cui
    Citation: Cardiovascular Diabetology 2024 23:126
    Content type: Research Published on:

  10. Coronary microvascular dysfunction (CMD) is a frequent complication of diabetes mellitus (DM) characterized by challenges in both diagnosis and intervention. Circulating levels of microRNAs are increasingly re...

    Authors: Yihai Liu, Chongxia Zhong, Shan Chen, Yanan Xue, Zhonghai Wei, Li Dong and Lina Kang
    Citation: Cardiovascular Diabetology 2024 23:60
    Content type: Research Published on:

  11. Atherosclerosis is one of the leading causes of death worldwide. miR-26 is a potential biomarker of atherosclerosis. Standardized diagnostic tests for miR-26 (MIR26-DX) have been developed, but the fastest pro...

    Authors: Wujun Chen, Xiaolin Wu, Jianxia Hu, Xiaolei Liu, Zhu Guo, Jianfeng Wu, Yingchun Shao, Minglu Hao, Shuangshuang Zhang, Weichao Hu, Yanhong Wang, Miao Zhang, Meng Zhu, Chao Wang, Yudong Wu, Jie Wang…
    Citation: Cardiovascular Diabetology 2024 23:21
    Content type: Review Published on:

  12. Diabetic cardiomyopathy (DCM) is a major complication of diabetes and a risk factor for cardiovascular disease. Endothelial dysfunction is central to DCM, and endothelial-to-mesenchymal transition (EndMT) is a...

    Authors: Eric Wang, Shali Chen, Honglin Wang, Tori Chen and Subrata Chakrabarti
    Citation: Cardiovascular Diabetology 2023 22:303
    Content type: Research Published on:

  13. Circulating MicroRNAs (miRNAs) carried by microvesicles (MVs) have various physiological and pathological functions by post-transcriptional regulation of gene expression being considered markers for many disea...

    Authors: Miruna Nemecz, Diana Simona Stefan, Ioana Karla Comarița, Alina Constantin, Gabriela Tanko, Cristian Guja and Adriana Georgescu
    Citation: Cardiovascular Diabetology 2023 22:260
    Content type: Research Published on:

  14. MicroRNAs (miRNAs) play a crucial role in regulating adaptive and maladaptive responses in cardiovascular diseases, making them attractive targets for potential biomarkers. However, their potential as novel bi...

    Authors: Mehrdad Samadishadlou, Reza Rahbarghazi, Zeynab Piryaei, Mahdad Esmaeili, Çığır Biray Avcı, Farhad Bani and Kaveh Kavousi
    Citation: Cardiovascular Diabetology 2023 22:247
    Content type: Research Published on:

  15. Atherogenic index of plasma (AIP) has been confirmed as a novel marker for myocardial infarction (MI), but few evidence on the long-term AIP and MI risk in general populations. We thus aimed to evaluate the re...

    Authors: Yijun Zhang, Shuohua Chen, Xue Tian, Penglian Wang, Qin Xu, Xue Xia, Xiaoli Zhang, Jing Li, Fen Liu, Shouling Wu and Anxin Wang
    Citation: Cardiovascular Diabetology 2023 22:210
    Content type: Research Published on:

  16. Diabetes mellitus, a group of metabolic disorders characterized by high levels of blood glucose caused by insulin defect or impairment, is a major risk factor for cardiovascular diseases and related mortality....

    Authors: Gaia Spinetti, Martina Mutoli, Simona Greco, Federica Riccio, Soumaya Ben-Aicha, Franziska Kenneweg, Amela Jusic, David de Gonzalo-Calvo, Anne Yaël Nossent, Susana Novella, Georgios Kararigas, Thomas Thum, Costanza Emanueli, Yvan Devaux and Fabio Martelli
    Citation: Cardiovascular Diabetology 2023 22:122
    Content type: Review Published on:

About the collection

Cardiovascular Diabetology is calling for submissions to our Collection on Functional roles of non-coding RNAs in cardiovascular diabetology. Non-coding RNAs have recently emerged as fundamental players in a number of physiologic and pathologic processes. This Collection, edited by Prof. Gaetano Santulli, MD, PhD, is open to both original articles and systematic reviews focusing on non-coding RNAs in the field of cardiovascular diabetology, with the ultimate goal to provide a comprehensive, state-of-the-art overview on this intriguing topic. We are interested in considering manuscripts exploring key aspects of non-coding RNA in basic science as well as in clinical practice, for instance examining their applications as reliable biomarkers of disease and their employment as therapeutic tools.

Submission Guidelines

Back to top

This Collection welcomes submission of Research Articles, Data Notes, Case Reports, Study Protocols, and Database Articles. Before submitting your manuscript, please ensure you have read our submission guidelines. Articles for this Collection should be submitted via our submission system, Snapp. During the submission process you will be asked whether you are submitting to a Collection, please select "Functional roles of non-coding RNAs in cardiovascular diabetology" from the dropdown menu.

Articles will undergo the journal’s standard peer-review process and are subject to all of the journal’s standard policies. Articles will be added to the Collection as they are published.

The Guest Editors have no competing interests with the submissions which they handle through the peer review process. The peer review of any submissions for which the Guest Editors have competing interests is handled by another Editorial Board Member who has no competing interests.